OPHTECS Global Team Welcomes Dr. Schnider, One of Most Influential Women in Optical Industry and One of World’s Most Prominent Contact Lens Researchers and Educators
- Enforcing Company's R&D Efforts for New Lens Care Products and Global Professional Relation Activities - KOBE, Japan, Jan. 17, 2023 /PRNewswire/ -- OPHTECS Corporation (hereinafter referred to as OPHTECS), a Kobe-based company which researches, develops, produces and markets contact lens care products, has signed a new advisory contract with Dr. Cristina M. Schnider as the company's Senior Director, Global...
Organon Is Recognized as Both “Top Employers China 2023” And “Best Workplaces™ in Greater China 2022”
SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Today, Organon China is proud to have been named the "2023 Top Employers in China" and honored to receive "Best Workplaces™ in Greater China 2022" certificate, in recognizing its vision-driven company culture, diversity and inclusion, strong employer brand, attractive work environment and company's long-term commitment in ESG. The company stands out as one of...
Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer
MANNHEIM, Germany, WATCHUNG, N.J. and SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Full-Life Technologies today announced the appointments of Steffen Heeger, MD, PhD, as Chief Medical Officer (CMO) and Fa Liu, PhD as Chief Scientific Officer (CSO). Dr. Heeger has held senior oncology clinical development positions at both large and emerging companies for more than 15 years. His work was...
Ascletis Announces Entering into a Supply Agreement of Ritonavir Tablets with Simcere
HANGZHOU and SHAOXING, China, Jan. 17, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that its wholly owned subsidiary Ascletis Pharmaceuticals Co., Ltd. has entered into a supply agreement of ritonavir tablets with Hainan Simcere Pharmaceutical Co., Ltd., a subsidiary of Simcere Pharmaceutical Group Limited (HKEX: 2096, "Simcere"). Ritonavir tablet is a pharmacokinetic booster of...
FDA Accepts GMP Plasmid DMF of OBiO Technology
SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- OBiO Technology (Shanghai) Corp., Ltd. ('OBiO', 688238.SH), a gene and cell therapy-focused contract research organization (CRO) and contract development and manufacturing organization (CDMO), recently announced that the United States Food and Drug Administration (FDA) has accepted its GMP plasmid DNA drug master file (DMF), DMF...
AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China
Affamed to obtain sole commercialization rights upon regulatory approval in Mainland China to Galcanezumab, a monoclonal antibody that selectively binds to calcitonin gene-related peptide (CGRP). Target to address unmet medical needs for millions of Chinese migraine patients. SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to address critical unmet medical needs in...
Agilis RoboticsTM Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery
HONG KONG, Jan. 17, 2023 /PRNewswire/ -- Agilis RoboticsTM (Agilis), a leading developer of flexible robotic instruments that support endoscopic surgery through natural orifices of the body (e.g. along the gastrointestinal tract and in the bladder), has recently completed the second round of live animal testing using its proprietary robot. Dr. Jason Y.K. Chan, the co-founder of Agilis RoboticsTM...
AMCOR EXPANDS HEALTHCARE PLATFORM IN THE ASIA PACIFIC REGION WITH ACQUISITION OF MDK
Complementary capabilities, product offering, and customer base solidifies leadership position in priority high growth medical device packaging segment ZURICH, Jan. 17, 2023 /PRNewswire/ -- Amcor (NYSE: AMCR) (ASX:AMC), a global leader in developing and producing responsible packaging solutions, today announced it has entered into an agreement to acquire Shanghai-based MDK. MDK generates annual sales of approximately $50 million...
FAPON presents at 41st Annual J.P. Morgan Healthcare Conference
SHENZHEN, China, Jan. 16, 2023 /PRNewswire/ -- FAPON, a leading life sciences company, announced that Mr. Jielun ZHU, the company's Chief Financial Officer (CFO) and Chief Investment Officer (CIO), has presented at the 41st Annual J.P. Morgan Healthcare Conference and shared FAPON's development, achievements and future plans in life sciences. In outlining the company's initiatives to extend its technological...
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China
SHANGHAI, Jan. 16, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, and Huadong Medicine (Hangzhou) Co., Ltd., a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (Huadong Medicine; SZ: 000963), today announced a collaboration for the commercialization...
